• <listing id="vvvzt"></listing>
    <code id="vvvzt"></code>

    1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
    2. <output id="vvvzt"></output>
      <code id="vvvzt"></code>
            <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
              1. <listing id="vvvzt"></listing>

              2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

              3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                <label id="vvvzt"></label>
                  <label id="vvvzt"></label>
                      <code id="vvvzt"></code>
                    1. <output id="vvvzt"><video id="vvvzt"></video></output>
                    2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                          1. http://www.tyds.icu
                            Home > Products > Anticancer/Antitumor/Antineoplastic > Ibrutinib api cas 936563-96-1 Ibrutinib intermediate

                            Ibrutinib api cas 936563-96-1 Ibrutinib intermediate

                            Basic Info

                            Function: Antineoplastic

                            Product Description

                            Chemical Name: Ibrutinib
                            Molecular Formula: C25H24N6O2
                            Formula Weight: 440.5
                            CAS No.: 936563-96-1

                            936563-96-1



                            Ibrutinib is used to treat chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, marginal zone lymphoma, and chronic graft vs host disease
                            Ibrutinib is a kind of Bruton tyrosine kinase (BTK) inhibitor, it could be used for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). MCL and CLL are belonged to the B-cell non-Hodgkin's lymphoma, which is difficult to cure and easy to recurrent. Common chemical immunotherapy does not have the targeting, often occurs 3 or 4 adverse reactions. Ibrutinib and B lymphocytes could target with BTK which is necessary for formation, differentiation, and transmission of information, inhibit BTK activity irreversibly, and inhibit tumor cell proliferation and survival effectively.
                            Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstr?m's macroglobulinemia

                            Looking for ideal Anticancer Active Ingredient Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Btk Inhibitor 1 R EnantioMer are quality guaranteed. We are China Origin Factory of Ibrutinib N-1 Intermediate Anticancer. If you have any question, please feel free to contact us.

                            Product Categories : Anticancer/Antitumor/Antineoplastic

                            Email to this supplier
                            • *Subject:
                            • *Messages:
                              Your message must be between 20-8000 characters
                            Communicate with Supplier?Supplier
                            Mr. Vid Mr. Mr. Vid
                            What can I do for you?
                            Contact Supplier
                            浙江快乐彩走势图快乐12基本走势图
                          2. <listing id="vvvzt"></listing>
                            <code id="vvvzt"></code>

                            1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
                            2. <output id="vvvzt"></output>
                              <code id="vvvzt"></code>
                                    <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
                                      1. <listing id="vvvzt"></listing>

                                      2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

                                      3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                                        <label id="vvvzt"></label>
                                          <label id="vvvzt"></label>
                                              <code id="vvvzt"></code>
                                            1. <output id="vvvzt"><video id="vvvzt"></video></output>
                                            2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                                                  1. <listing id="vvvzt"></listing>
                                                    <code id="vvvzt"></code>

                                                    1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
                                                    2. <output id="vvvzt"></output>
                                                      <code id="vvvzt"></code>
                                                            <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
                                                              1. <listing id="vvvzt"></listing>

                                                              2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

                                                              3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                                                                <label id="vvvzt"></label>
                                                                  <label id="vvvzt"></label>
                                                                      <code id="vvvzt"></code>
                                                                    1. <output id="vvvzt"><video id="vvvzt"></video></output>
                                                                    2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                                                                          1. pc蛋蛋预测网 权杖女王电子游艺 19年动物足球游戏 奇迹觉醒哪个职业最强 边锋三国杀手游官方版 马德里竞技股东 河南快赢481开奖直播 香港六合彩开奖 广东快乐10分钟 李逵劈鱼怎么玩 pt古怪猴子大奖截图 记忆盛宴试玩 圣埃蒂安VS里尔比分预测 迷你世界怎么做自动门 塞维利亚vs拉齐奥 正在视频直播活塞vs湖人